Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study
Cancer Immunology, Immunotherapy · 2026
DOI: 10.1007/s00262-026-04472-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2026. Verfasst von Lin Zhang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, C…. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitors, Nasopharyngeal Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China.
- Hunan Key Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Province, Changsha, People's Republic of…
- Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China. liyanxian@hnca.org…
- Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China. wanghui@hnca.org.c…
- Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, People's Republic of China. liuhuai@hnca.org.c…
ORCID-Profile: Huai Liu
Zitieren
APA
Zhang, L., Gan, X., Yu, Z., Xie, W., Sun, X., Li, Y., Fang, J., Liu, Y., Liu, Z., Tang, Y., Zhou, C., Xie, Z., Ouyang, S., Zhang, J., Wang, J., Li, H., Liu, F., Chen, P., Li, Y., …, & Liu, H. (2026). Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04472-2
Vancouver
Zhang L, Gan X, Yu Z, Xie W, Sun X, Li Y, et al. Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04472-2
BibTeX
@article{Zhang2026,
author = {Zhang, Lin and Gan, Xia and Yu, Zhengzheng and Xie, Wenji and Sun, Xiaowen and Li, Yue and Fang, Jianing and Liu, Yating and Liu, Zhongjie and Tang, Yaning and Zhou, Can and Xie, Zhuolong and Ouyang, Shuyu and Zhang, Jing and Wang, Jingyu and Li, Hua and Liu, Feng and Chen, Pan and Li, Yanxian and Wang, Hui and Liu, Huai},
title = {Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
doi = {10.1007/s00262-026-04472-2}
}
EUVIMED